Sepsis, Shock, and DIC

Overview of Course Session

• Speaker addresses specific test questions and clarifies common misconceptions from the recorded lecture, guiding students to focus on high-yield topics. Topics covered often include fluid balance, electrolyte imbalances, and patient assessment in acute care settings.

• Encourages students to thoroughly review Chapter 10, "Shock and Multiple Organ System Failure," from their ED Med Search book, as the upcoming test aligns closely with this comprehensive material. This chapter covers the pathophysiology, clinical manifestations, and management of various shock states.

• Introduces Dr. Collins, a new instructor bringing over a decade of significant nursing experience, including critical care, emergency medicine, and serving as a travel nurse during the challenging COVID-19 pandemic, which involved managing a wide range of critically ill patients.

• Outlines today's lecture topics: an in-depth discussion on Shock and Sepsis, integrating realistic case studies to illustrate complex clinical scenarios, and a detailed exam review PowerPoint presentation that will be posted on the learning management system for student access.

Instructor Updates and Announcements

Clinical Observations

• Dr. Collins notes that a student, Kimmy, will be absent from clinical next week due to a crucial follow-up appointment, and arrangements are being finalized for her make-up session.

• Plans are underway for students to observe school nursing for 1-2 days, providing valuable, albeit limited, pediatric exposure. This typically involves observing medication administration, first aid, and management of chronic conditions in school-aged children.

• Observations from previous students have consistently indicated positive feedback, highlighting successful learning experiences and high satisfaction with the insights gained into community health and pediatric care.

• Students are advised to await final confirmation from ISD (Instructional Services Department) regarding specific student placements and schedules to ensure smooth coordination and proper access.

• A Google Sheet will be posted shortly for students to conveniently sign up for available observation days, allowing them to select slots that best fit their schedules.

Graduation and Licensing

• Reminds students about the imperative necessity of initiating background checks and submitting their application for graduation, emphasizing the critical 'blue card' process, which is essential for processing licensure applications with the Board of Nursing.

• Students are queried if they've completed registration with the State Board of Nursing; close monitoring will ensue to ensure every student's application is correctly and promptly processed to avoid delays in licensure.

• Strong emphasis is placed on timely NCLEX testing post-graduation—ideally within two months of graduation. This timeframe is crucial as studies show a higher success rate for graduates who test sooner, retaining fresh academic knowledge and clinical skills.

Introduction to Shock and Sepsis

• Dr. Collins details her extensive background: over ten years of diverse nursing experience, specializing in high-acuity areas like the ICU (Intensive Care Unit) and ER (Emergency Room), and recently completing training in 2024 to become a psychiatric nurse practitioner.

Definition of Sepsis

• Sepsis is meticulously defined as a life-threatening condition stemming from the body's extreme and gravely dysregulated immune response to an infection. Instead of effectively combating the invading pathogens, the immune system overreacts catastrophically, unleashing a systemic inflammatory response that indiscriminately attacks and harms its own healthy tissues and organs, frequently leading to profound multi-organ damage.

Early Signs of Sepsis

• Symptoms can include:

  • Fever ($>38^\text{o}C$ or $100.4^\text{o}F$) or hypothermia ($<36^\text{o}C$ or $96.8^\text{o}F$).

  • Tachycardia (heart rate $>90$ bpm), a compensatory response to maintain cardiac output in the face of vasodilation.

  • Tachypnea (respiratory rate $>20$ breaths per minute) or an arterial partial pressure of carbon dioxide ($PaCO_2$) $<32$ mmHg, indicating respiratory compensation for metabolic acidosis.

  • Altered white blood cell count ($>12,000$ $cells/\text{mm}^3$ or $<4,000$ $cells/\text{mm}^3$ or $>10$% immature bands), reflecting a severe immune response.

  • General appearance of illness, often presenting as malaise, confusion, or a feeling of impending doom.

• The importance of identifying these early signs is paramount to initiating timely interventions. Delay in treatment significantly increases morbidity and mortality.

• Use of SIRS (Systemic Inflammatory Response Syndrome) criteria helps in the early diagnosis, though current definitions emphasize organ dysfunction (Sequential Organ Failure Assessment or SOFA score).

Cytokines and Immune Response

• Cytokines, such as TNF-alpha, IL-1, and IL-6, play a pivotal role in mediating both inflammation and tissue damage during sepsis. Their overproduction creates a cytokine storm.

• Their excessive release leads to:

  • Profound blood vessel permeability and subsequent leakage of intravascular fluids into the interstitial spaces (third spacing), causing widespread edema and reducing effective circulating blood volume.

  • A significant drop in blood pressure (hypotension) and a severe loss of effective tissue perfusion and circulation, leading to inadequate oxygen delivery to cells.

• This dysregulated response also triggers the coagulation cascade, leading to the creation of widespread microthrombi (tiny clots) that obstruct blood flow within capillaries, resulting in vascular obstruction and ischemia, particularly affecting vital organs such as the lungs (leading to ARDS), brain (encephalopathy, stroke), and heart (myocardial dysfunction).

Treatment Procedures and Nursing Interventions for Sepsis

Initial Treatment Steps (Sepsis Bundle - within 1 hour)

1. Obtain a lactate level immediately; if the level is $>2$ mmol/L, it indicates tissue hypoperfusion and necessitates aggressive treatment. A level $>4$ mmol/L signals severe lactate acidosis.

2. Draw at least two sets of blood cultures (one aerobic, one anaerobic from two different sites) before administering antibiotics to ensure accurate identification of the causative pathogen and avoid contamination that could skew results.

3. Administer broad-spectrum intravenous (IV) antibiotics shortly after cultures are drawn, ideally within the first hour of recognition. Broad-spectrum antibiotics cover a wide range of potential bacterial pathogens.

4. Initiate aggressive fluid resuscitation:

   • Administer $30$ mL/kg of crystalloid fluids (e.g., normal saline or Lactated Ringer's solution) intravenously within the first three hours. The goal is to restore effective circulating volume and improve tissue perfusion, targeting a mean arterial pressure ($MAP$) of at least $65$ mmHg.

5. Consider vasopressors if fluid resuscitation alone is inadequate to maintain a MAP $>65$ mmHg and SBP $>90$ mmHg. Norepinephrine is typically the first-line vasopressor due to its potent vasoconstrictive effects.

6. Implement source control and continuous monitoring. This involves identifying and eradicating the source of infection (e.g., draining an abscess, removing an infected catheter, debriding necrotic tissue, or surgical intervention).

Key Takeaways on Sepsis

• Early identification and prompt initiation of the sepsis bundle are critically important to improving patient outcomes and reducing mortality. Every hour of delay increases the risk of adverse events.

• Continuously monitor blood lactate levels as a dynamic marker of tissue perfusion and hypoxia. Trending lactate levels downwards indicates effective resuscitation.

• Consequences of untreated or poorly managed sepsis can be severe and long-lasting, including persistent cognitive impairment (often referred to as 'post-sepsis syndrome'), amputations due to peripheral tissue death (gangrene from DIC), chronic pain, and permanent organ damage leading to conditions like chronic kidney disease or heart failure.

Disseminated Intravascular Coagulation (DIC)

• DIC is a serious and complex condition that can develop as a severe complication of sepsis, where the body's clotting cascade becomes pathologically overactivated throughout the microvasculature. This widespread activation leads to the paradoxical combination of widespread microclot formation, which obstructs blood flow and consumes clotting factors (platelets, fibrinogen, factor V, factor VIII), simultaneously causing severe bleeding from multiple sites.

• Clinical signs and symptoms may involve:

  • Organ dysfunction due to microthrombi in small vessels, leading to acute kidney injury, acute respiratory distress syndrome (ARDS), or hepatic dysfunction.

  • Neurological symptoms such as confusion, altered mental status, or stroke-like symptoms resulting from microvascular compromise in the brain.

  • Characteristic mucocutaneous manifestations, including petechiae (small pinpoint hemorrhages), ecchymoses (bruising), purpura fulminans (large, rapidly expanding purplish lesions with necrosis), and acrocyanosis (bluish discoloration of extremities).

• DIC requires urgent recognition and aggressive management, focusing on addressing the underlying causes (e.g., treating the primary infection in sepsis) and often involves supportive therapies like transfusions of blood products (platelets, fresh frozen plasma, cryoprecipitate) to replace consumed clotting factors, though heparin use remains controversial and context-dependent.

Defining Shock

• Shock is a critical clinical syndrome characterized by widespread inadequate tissue perfusion, leading to cellular hypoxia and impaired cellular metabolism. This shift from aerobic to anaerobic metabolism results in insufficient ATP production, accumulation of lactic acid, cellular swelling, and ultimately, cell death. Immediate and aggressive management is essential, as untreated or refractory shock inevitably results in multi-organ dysfunction and death.

• It can progress through four interconnected stages:

  1. Initial Stage: This is a subtle, non-clinical stage where cellular changes begin due to hypoperfusion. Cellular metabolism shifts from aerobic to anaerobic, producing lactic acid. Clinical signs are usually absent unless specific laboratory tests, such as elevated lactic acid levels ($>2$ mmol/L), are performed.

  2. Compensatory Stage: The body activates various homeostatic mechanisms to maintain vital organ perfusion. This involves activation of the sympathetic nervous system (releasing catecholamines like epinephrine and norepinephrine, leading to tachycardia, vasoconstriction, and tachypnea) and the renin-angiotensin-aldosterone system (RAAS) to promote fluid retention. Clinically, patients may exhibit a normal blood pressure (due to vasoconstriction), cool and clammy skin (except in early septic shock), decreased urine output, and restless behavior.

  3. Progressive Stage: Compensatory mechanisms begin to fail, leading to significant hypoperfusion at the cellular level despite ongoing efforts. Widespread cellular dysfunction becomes apparent, with signs including worsening hypotension, altered mental status (lethargy, confusion), and specific organ dysfunction (e.g., acute kidney injury, acute respiratory distress syndrome - ARDS, gastrointestinal ischemia). This stage requires aggressive medical intervention to prevent irreversible damage.

  4. Irreversible (Refractory) Stage: Characterized by severe, widespread cellular and organ damage that is unresponsive to therapeutic interventions. Profound hypotension persists despite vasopressor support, leading to multi-organ failure (MODS). At this point, cellular death is so extensive that recovery is unlikely, and management shifts towards palliative care.

Classification of Types of Shock

Types of Shock:

1. Hypovolemic Shock

   • Definition: Results from a significant and rapid loss of intravascular blood volume, causing inadequate organ perfusion. This loss can be absolute (external hemorrhage) or relative (fluid shifts into third spaces).

   • Causes: Can categorize into hemorrhagic (e.g., severe trauma, gastrointestinal bleeding, ruptured aneurysm, surgery) and non-hemorrhagic (e.g., severe vomiting/diarrhea, extensive burns, severe dehydration, diabetic ketoacidosis, third-spacing like ascites).

   • Symptoms: Characterized by pronounced tachycardia ($>100$ bpm), hypotension, cool and clammy skin (due to peripheral vasoconstriction to shunt blood to vital organs), weak and thready peripheral pulses, decreased urine output ($<0.5$ mL/kg/hr), flattened neck veins, and altered mental status.

   • Interventions: Aggressive fluid resuscitation with isotonic crystalloids (e.g., Normal Saline, Lactated Ringer's). For hemorrhagic shock, rapid administration of blood products (pRBCs, platelets, FFP) is crucial, alongside identifying and stopping the source of blood loss.

2. Cardiogenic Shock

   • Definition: Occurs when the heart's pumping ability is severely impaired, leading to a significant reduction in cardiac output and systemic hypoperfusion, despite adequate intravascular volume.

   • Causes: Most commonly caused by acute myocardial infarction (MI) leading to extensive left ventricular dysfunction, but also includes severe heart failure exacerbation, cardiac arrhythmias, valvular diseases (e.g., severe aortic stenosis), and profound cardiomyopathies.

   • Symptoms: Manifests as a weak and thready pulse, persistent tachycardia, significant hypotension, signs of pulmonary congestion (e.g., crackles on auscultation, dyspnea, increased work of breathing), jugular venous distension (JVD), S3/S4 heart sounds, and cool, clammy skin.

   • Interventions: Inotropic agents (e.g., Dobutamine, Milrinone) to enhance myocardial contractility, careful fluid management (fluid bolus only if clear signs of hypovolemia are present, otherwise diuretics), vasodilators (e.g., nitroglycerin) to reduce afterload, and mechanical circulatory support (e.g., Intra-Aortic Balloon Pump - IABP, Ventricular Assist Devices - VAD). Revascularization (PCI or CABG) is critical if the cause is MI.

3. Obstructive Shock

   • Definition: Arises from a physical obstruction within the great vessels or heart, impeding cardiac output by preventing adequate blood flow to or from the heart.

   • Causes: Includes cardiac tamponade (fluid accumulation in the pericardial sac), tension pneumothorax (air accumulation in the pleural space collapsing the lung and shifting mediastinum), massive pulmonary embolism (PE blocking pulmonary arterial flow), and severe aortic stenosis.

   • Symptoms: Characterized by hypotension, often with JVD, muffled heart sounds (in cardiac tamponade), tracheal deviation (in tension pneumothorax), pulsus paradoxus (exaggerated drop in systolic BP during inspiration), and sudden onset of chest pain and dyspnea (in PE).

   • Interventions: Requires immediate identification and treatment of the underlying obstruction. This may involve pericardiocentesis for tamponade, needle decompression followed by chest tube insertion for tension pneumothorax, thrombolytics or embolectomy for massive PE, or surgical intervention for severe valvular disease.

4. Distributive Shock

   • Definition: Characterized by widespread vasodilation, resulting in a maldistribution of blood flow and inadequate tissue perfusion, despite often normal or even increased intravascular volume. This involves dysregulation of vascular tone and increased capillary permeability.

   • Subtypes:

     • Septic Shock: Defined as a subset of sepsis with persistent hypotension requiring vasopressors to maintain a MAP $>65$ mmHg and SBP $>90$ mmHg, despite adequate fluid resuscitation ($30$ mL/kg). It is caused by severe infection leading to a profound systemic inflammatory response.

     • Symptoms: Often presents with warm and flushed skin (early phase due to vasodilation), followed by cool and mottled skin (late phase), altered mental status (sepsis-associated encephalopathy), and decreased urine output.

     • Interventions: All initial sepsis treatment steps (cultures, broad-spectrum antibiotics, fluid resuscitation) are critical, with prompt initiation and titration of vasopressors (Norepinephrine first-line) to maintain target MAP, along with source control of infection.

     • Neurogenic Shock: Results from a loss of sympathetic nervous system tone, typically due to spinal cord injury (most commonly above T6). This leads to unopposed parasympathetic activity.

     • Symptoms: Classical presentation includes profound hypotension, often accompanied by bradycardia (due to loss of sympathetic innervation to the heart), and warm, dry skin (peripheral vasodilation).

     • Interventions: Focus on stabilizing the spinal injury, cautious fluid administration, vasopressors (e.g., Phenylephrine, Norepinephrine) to restore vascular tone, and atropine for symptomatic bradycardia.

     • Anaphylactic Shock: A severe, life-threatening systemic hypersensitivity (allergic) reaction, typically rapid in onset and involving profound vasodilation and increased capillary permeability.

     • Causes: Triggered by exposure to specific allergens (e.g., foods, medications, insect stings, latex).

     • Symptoms: Rapid onset, including severe bronchospasm (wheezing, dyspnea), angioedema (swelling of lips, face, throat), urticaria (hives), profound hypotension, tachycardia, and gastrointestinal symptoms (nausea, vomiting, abdominal cramps).

     • Interventions: Immediate administration of intramuscular (IM) epinephrine is crucial. Additional treatments include antihistamines (H1 and H2 blockers), corticosteroids to reduce inflammation, bronchodilators (e.g., albuterol) for bronchospasm, and securing the airway if angioedema is severe.

Conclusion and Recap

• The lecture emphasizes the paramount importance of early recognition and timely, aggressive intervention in effectively managing shock and sepsis. Delays significantly worsen patient prognosis.

• It differentiates between the various types of shock (hypovolemic, cardiogenic, obstructive, distributive) and underscores the critical importance of understanding their unique pathophysiology, distinct clinical presentations, and tailored management strategies.

• The instructor opens the floor for questions, ensuring comprehensive understanding of the complex material discussed during the lecture, and addresses any remaining uncertainties.